Schedule 13G ownership disclosure

FUSION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 36118A100

Event date: 2023-10-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-23-005782
Form type
SC 13G
Filer
Avidity Partners Management LP
CIK
CIK 1791827
Filed
Oct 23, 2023
Reporting period
Oct 18, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub